Skip to main content
Fig. 8 | BMC Complementary Medicine and Therapies

Fig. 8

From: Network pharmacology and experimental validation to study the potential mechanism of Tongguanteng injection in regulating apoptosis in osteosarcoma

Fig. 8

Molecular docking results of vital active components with target proteins. The blue portions represent the target proteins, while the green portions indicate the compounds. The yellow dashed lines represent the interactions between the ligands and the receptors. A JUN with Tenacissoside J, (B) PTGS2 with Marsdekoiside, (C) AR with Tenacissoside J, (D) VEGFA with Tenacissoside J, (E) CDK1 with Tenacissoside L, (F) ESR1 with Tenacissoside L form stable complex

Back to article page